Parnell Pharmaceuticals Holdings Ltd Company Profile (NASDAQ:PARN)

About Parnell Pharmaceuticals Holdings Ltd

Parnell Pharmaceuticals Holdings Ltd logoParnell Pharmaceuticals Holdings Limited is a veterinary pharmaceutical company. The Company is focused on developing, manufacturing and commercializing animal health solutions. The principal activities of the Company include manufacture for global sale of animal pharmaceutical product, and research and development of pharmaceutical products for global animal health markets. The Company operates through four segments: Companion Animal, Production Animal-U.S., Production Animal-Rest of World and Manufacturing Operations. It augments its pharmaceutical products with its FETCH and mySYNCH software platforms. It offers disease-modifying product, Zydax, for the treatment of osteoarthritis (OA). Its reproductive hormone products include estroPLAN and GONAbreed. It has a nutraceutical product, Glyde. It also markets a non-steroidal anti-inflammatory drug (NSAID), called Tergive. It is developing a pipeline of clinical drug candidates, such as PAR 121, PAR 122, PAR 101, PAR 081 and PAR 061.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: PARN
  • CUSIP:
Key Metrics:
  • Previous Close: $1.50
  • 50 Day Moving Average: $1.55
  • 200 Day Moving Average: $1.80
  • 52-Week Range: $1.34 - $4.89
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.94
  • P/E Growth: 0.00
  • Market Cap: $22.02M
  • Outstanding Shares: 14,679,000
  • Beta: -0.27
Additional Links:
Companies Related to Parnell Pharmaceuticals Holdings Ltd:

Analyst Ratings

Consensus Ratings for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.50 (733.33% upside)

Analysts' Ratings History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Show:
DateFirmActionRatingPrice TargetDetails
5/24/2016Dawson JamesReiterated RatingBuyView Rating Details
4/1/2016Jefferies GroupReiterated RatingBuy$18.00 -> $16.00View Rating Details
2/29/2016Piper Jaffray Cos.Reiterated RatingOverweight$12.00 -> $9.00View Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/19/2016        
10/21/2015Q3($0.22)($0.13)ViewListenView Earnings Details
8/11/2015Q2($0.26)($0.19)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
Current Year EPS Consensus Estimate: $-1.53 EPS
Next Year EPS Consensus Estimate: $-1.60 EPS

Dividends

Dividend History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)
DateHeadline
kcregister.com logoToday's Hot List: 3M Company (NYSE:MMM), Parnell Pharmaceuticals Holdings Ltd. (NASDAQ:PARN), Pinnacle ... - KC Register (NASDAQ:PARN)
www.kcregister.com - September 25 at 5:57 PM
News IconUnder the Microscope, Zeroing in at Parnell Pharmaceuticals Holdings Ltd. (NASDAQ:PARN) - Duncan Research (NASDAQ:PARN)
www.duncanindependent.com - September 22 at 6:21 PM
News IconPenny Stock Investors Take an Interest in Parnell Pharmaceuticals Holdings Ltd. (NASDAQ:PARN) - Duncan Research (NASDAQ:PARN)
www.duncanindependent.com - September 21 at 10:45 AM
News IconPlacing Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Shares Under the Microscope - Post News (NASDAQ:PARN)
www.kentuckypostnews.com - September 9 at 6:19 PM
News IconSell-side & Crowd View on Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - Post News (NASDAQ:PARN)
www.kentuckypostnews.com - August 21 at 5:57 PM
investornewswire.com logoWill Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Hit $12 Price Target? - Investor Newswire (NASDAQ:PARN)
www.investornewswire.com - August 21 at 5:57 PM
News IconWhat Does the Consensus Have to Say About Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Shares? - Post News (NASDAQ:PARN)
www.kentuckypostnews.com - August 19 at 9:45 AM
finance.yahoo.com logoPARN: Revenue Growth of 67% in 1H16; Gearing up for Zydax® Approval in 2Q17… (NASDAQ:PARN)
finance.yahoo.com - August 11 at 7:12 PM
finance.yahoo.com logoEdited Transcript of PARN earnings conference call or presentation 4-Aug-16 12:00pm GMT (NASDAQ:PARN)
finance.yahoo.com - August 8 at 11:25 AM
reuters.com logoBRIEF-Parnell Pharmaceuticals sees FY 2016 revenue of $14 million to $16 million (NASDAQ:PARN)
www.reuters.com - August 5 at 9:46 AM
reuters.com logoBRIEF-Parnell Pharmaceuticals sees FY 2016 revenue of $14 million to $16 million - Reuters (NASDAQ:PARN)
www.reuters.com - August 4 at 9:54 AM
nasdaq.com logoParnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016 - Nasdaq (NASDAQ:PARN)
www.nasdaq.com - August 4 at 9:54 AM
biz.yahoo.com logoQ2 2016 Parnell Pharmaceuticals Holdings Ltd Earnings Release - 07:00 am ET (NASDAQ:PARN)
biz.yahoo.com - August 4 at 9:54 AM
publicnow.com logoParnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016 (NASDAQ:PARN)
www.publicnow.com - August 4 at 9:54 AM
ftsenews.co.uk logoNew Broker Ratings For Parnell Pharmaceuticals Holdings Ltd (PARN) - FTSE News (NASDAQ:PARN)
www.ftsenews.co.uk - July 26 at 7:02 PM
twst.com logoParnell Pharmaceuticals Holdings Ltd.: Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on ... - The Wall Street Transcript (NASDAQ:PARN)
www.twst.com - July 26 at 7:02 PM
publicnow.com logoParnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016 (NASDAQ:PARN)
www.publicnow.com - July 26 at 5:18 PM
investornewswire.com logoIs $16.11 Price Target Attainable For Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)? - Investor Newswire (NASDAQ:PARN)
www.investornewswire.com - July 25 at 11:07 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - TGP (NASDAQ:PARN)
telanaganapress.com - July 23 at 10:38 AM
news.cmlviz.com logoParnell Pharmaceuticals Holdings Ltd. Stock Technicals Hit Extreme Weakness - CML News (NASDAQ:PARN)
news.cmlviz.com - July 21 at 7:01 PM
News IconEquity Roundup: Stock Performance Focus on Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - Press Telegraph (NASDAQ:PARN)
presstelegraph.com - July 19 at 6:52 PM
investornewswire.com logoStrong Sell Calls For Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) At 0 - Investor Newswire (NASDAQ:PARN)
www.investornewswire.com - July 17 at 6:06 PM
News IconParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:PARN)
telanaganapress.com - July 14 at 10:17 AM
News IconTrading Performance and Target Watch for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - Press Telegraph (NASDAQ:PARN)
presstelegraph.com - July 12 at 6:57 PM
News IconCompany Stock Focus for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN): Which Way Will Shares Head? - Press Telegraph (NASDAQ:PARN)
presstelegraph.com - July 11 at 6:44 PM
investornewswire.com logoIs $16.11 Within Reach For Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN)? - Investor Newswire (NASDAQ:PARN)
www.investornewswire.com - July 10 at 6:02 PM
News IconCan Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:PARN)
www.engelwooddaily.com - July 7 at 9:37 AM
News IconParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Stock Update: Check on Ratings and Target Price - Telanagana Press (NASDAQ:PARN)
telanaganapress.com - July 7 at 9:37 AM
News IconStock Rating Watch and Earnings Insight for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - Press Telegraph (NASDAQ:PARN)
presstelegraph.com - July 7 at 9:37 AM
investornewswire.com logoParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Expected to Reach Highs Of $16 - Investor Newswire (NASDAQ:PARN)
www.investornewswire.com - July 4 at 5:59 PM
News IconKruuda on Poola rallil avapäeva järel oma klassis esimene, Pärn kolmas - Postimees (NASDAQ:PARN)
sport.postimees.ee - July 2 at 6:23 PM
News IconVictory for Priit Pärn Who Will Continue Teaching At Estonian Academy of Arts - Cartoon Brew (NASDAQ:PARN)
www.cartoonbrew.com - July 2 at 6:23 PM
News IconSuper Special stage opener in Poland classification (NASDAQ:PARN)
www.automobilsport.com - July 1 at 6:44 PM
News IconVictory for Priit Pärn Who Will Continue Teaching At Estonian Academy of Arts (NASDAQ:PARN)
www.cartoonbrew.com - July 1 at 6:44 PM
News IconParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Company Rating and Target Watch - Telanagana Press (NASDAQ:PARN)
telanaganapress.com - June 30 at 6:58 PM
News IconParnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:PARN)
www.engelwooddaily.com - June 29 at 9:32 AM
fiscalstandard.com logoParnell Pharmaceuticals Holdings Ltd (PARN) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:PARN)
www.fiscalstandard.com - June 29 at 9:32 AM
News IconShare Update and Earnings Review for Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - Press Telegraph (NASDAQ:PARN)
presstelegraph.com - June 29 at 9:32 AM
ftsenews.co.uk logoParnell Pharmaceuticals Holdings Ltd (PARN) Updated Price Targets - FTSE News (NASDAQ:PARN)
www.ftsenews.co.uk - June 26 at 5:52 PM
investornewswire.com logoStrong Sell Calls Recommendations For Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) At 0 - Investor Newswire (NASDAQ:PARN)
www.investornewswire.com - June 26 at 5:52 PM
fiscalstandard.com logoThis Weeks Broker Views For Parnell Pharmaceuticals Holdings Ltd (PARN) - Fiscal Standard (NASDAQ:PARN)
www.fiscalstandard.com - June 20 at 8:19 AM
investornewswire.com logoStrong Buy Calls Count For Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) At 2 - Investor Newswire (NASDAQ:PARN)
www.investornewswire.com - June 20 at 8:19 AM
investornewswire.com logoTrend Of Rating Given To Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - Investor Newswire (NASDAQ:PARN)
www.investornewswire.com - June 13 at 9:41 AM
News IconBuy, Sell Or Hold Rating For Parnell Pharmaceuticals Holdings Ltd (PARN)? - Share Trading News (NASDAQ:PARN)
www.sharetrading.news - June 2 at 9:44 AM
News IconParnell Pharmaceuticals Holdings Ltd (PARN) Receives “Buy” Rating from Dawson James - Let Me Know About This (NASDAQ:PARN)
www.lmkat.com - June 1 at 9:40 AM
News IconStock Review and Earnings Check on Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) - HNN (NASDAQ:PARN)
hintsnewsnetwork.com - June 1 at 9:40 AM
globenewswire.com logoParnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial - GlobeNewswire (press release) (NASDAQ:PARN)
globenewswire.com - June 1 at 9:40 AM
reuters.com logoBRIEF-Parnell Pharmaceuticals says manufacturing deal with Merial - Reuters (NASDAQ:PARN)
www.reuters.com - May 31 at 7:01 PM
nasdaq.com logoParnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial - Nasdaq (NASDAQ:PARN)
www.nasdaq.com - May 31 at 7:01 PM
publicnow.com logoParnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial (NASDAQ:PARN)
www.publicnow.com - May 31 at 4:13 PM

Social

Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff